An entry in the Oct. 11, 2004, issue of BioWorld Financial Watch failed to note that Lazard Freres & Co. was a co-manager of OSI Pharmaceuticals Inc.'s proposed follow-on offering.
Editor's note: The correction has been made in BioWorld Online.
To read more on related topics, click on one of the words below.